Exact Mass: 477.2488
Exact Mass Matches: 477.2488
Found 500 metabolites which its exact mass value is equals to given mass value 477.2488
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
EPOTHILONE C
An epothilone that is 1-oxacyclohexadec-13-ene-2,6-dione which is substituted by hydroxy groups at positions 4 and 9, methyl groups at positions 5, 5, 7, and 9, and by a (1E)-1-(2-methyl-1,3-thiazol-4-yl)prop-1-en-2-yl group at position 16 (the 4S,7R,8S,9S,13Z,16S stereoisomer).
1'-O-Acetylpaxilline
1-O-Acetylpaxilline is a mycotoxin from the mycelium of Emericella striata. Mycotoxin from the mycelium of Emericella striata
Almitrine
A respiratory stimulant that enhances respiration by acting as an agonist of peripheral chemoreceptors located on the carotid bodies. The drug increases arterial oxygen tension while decreasing arterial carbon dioxide tension in patients with chronic obstructive pulmonary disease. It may also prove useful in the treatment of nocturnal oxygen desaturation without impairing the quality of sleep. [PubChem] R - Respiratory system > R07 - Other respiratory system products > R07A - Other respiratory system products > R07AB - Respiratory stimulants COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C78272 - Agent Affecting Nervous System > C47795 - CNS Stimulant D019141 - Respiratory System Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
(4Z)-7-[(1S,2S,5R)-5-[([1,1'-Biphenyl]-4-yl)methoxy]-2-(morpholin-4-yl)-3-oxocyclopentyl]hept-4-enoic acid
Epothilone C
C28H35N3O4_(1R,3S,5R,7S,12S)-4,4,4,4,12,14-Hexamethyl-4H,13H-spiro[9,14-diazatetracyclo[5.5.2.0~1,9~.0~3,7~]tetradecane-5,8-[1,4]dioxepino[2,3-g]indole]-9,13(10H)-dione
Ala Phe Ile Gln
Ala Phe Leu Gln
Ala Phe Gln Ile
Ala Phe Gln Leu
Ala Ile Phe Gln
Ala Ile Gln Phe
Ala Lys Pro Tyr
Ala Lys Tyr Pro
Ala Leu Phe Gln
Ala Leu Gln Phe
Ala Met Arg Thr
Ala Met Thr Arg
Ala Pro Lys Tyr
Ala Pro Tyr Lys
Ala Gln Phe Ile
Ala Gln Phe Leu
Ala Gln Ile Phe
Ala Gln Leu Phe
Ala Arg Met Thr
Ala Arg Thr Met
Ala Thr Met Arg
Ala Thr Arg Met
Ala Tyr Lys Pro
Ala Tyr Pro Lys
Cys Ile Arg Ser
Cys Ile Ser Arg
Cys Leu Arg Ser
Cys Leu Ser Arg
Cys Arg Ile Ser
Cys Arg Leu Ser
Cys Arg Ser Ile
Cys Arg Ser Leu
Cys Arg Thr Val
Cys Arg Val Thr
Cys Ser Ile Arg
Cys Ser Leu Arg
Cys Ser Arg Ile
Cys Ser Arg Leu
Cys Thr Arg Val
Cys Thr Val Arg
Cys Val Arg Thr
Cys Val Thr Arg
Glu Lys Thr Thr
Glu Thr Lys Thr
Glu Thr Thr Lys
Phe Ala Ile Gln
Phe Ala Leu Gln
Phe Ala Gln Ile
Phe Ala Gln Leu
Phe Gly Arg Val
Phe Gly Val Arg
Phe Ile Ala Gln
Phe Ile Gln Ala
Phe Lys Pro Ser
Phe Lys Ser Pro
Phe Leu Ala Gln
Phe Leu Gln Ala
Phe Asn Val Val
Phe Pro Lys Ser
Phe Pro Ser Lys
Phe Gln Ala Ile
Phe Gln Ala Leu
Phe Gln Ile Ala
Phe Gln Leu Ala
Phe Arg Gly Val
Phe Arg Val Gly
Phe Ser Lys Pro
Phe Ser Pro Lys
Phe Val Gly Arg
Phe Val Asn Val
Phe Val Arg Gly
Phe Val Val Asn
Gly Phe Arg Val
Gly Phe Val Arg
Gly His His Lys
Gly His Lys His
Gly Lys His His
Gly Arg Phe Val
Gly Arg Val Phe
Gly Val Phe Arg
Gly Val Arg Phe
His Gly His Lys
His Gly Lys His
His His Gly Lys
His His Lys Gly
His Lys Gly His
His Lys His Gly
His Lys Pro Pro
His Pro Lys Pro
His Pro Pro Lys
His Pro Pro Gln
His Pro Gln Pro
His Gln Pro Pro
Ile Ala Phe Gln
Ile Ala Gln Phe
Ile Cys Arg Ser
Ile Cys Ser Arg
Ile Asp Lys Cys
Ile Phe Ala Gln
Ile Phe Gln Ala
Ile Lys Cys Asp
Ile Lys Asp Cys
Ile Lys Met Ser
Ile Lys Ser Met
Ile Met Lys Ser
Ile Met Asn Thr
Ile Met Gln Ser
Ile Met Ser Lys
Ile Gln Ala Phe
Ile Gln Phe Ala
Ile Arg Cys Ser
Ile Arg Ser Cys
Ile Ser Cys Arg
Ile Ser Lys Met
Ile Ser Met Lys
Ile Ser Arg Cys
Lys Ala Pro Tyr
Lys Ala Tyr Pro
Lys Glu Thr Thr
Lys Phe Pro Ser
Lys Phe Ser Pro
Lys Gly His His
Lys His Gly His
Lys His His Gly
Lys His Pro Pro
Lys Ile Met Ser
Lys Ile Ser Met
Lys Leu Met Ser
Lys Leu Ser Met
Lys Met Ile Ser
Lys Met Leu Ser
Lys Met Ser Ile
Lys Met Ser Leu
Lys Met Thr Val
Lys Met Val Thr
Lys Pro Ala Tyr
Lys Pro Phe Ser
Lys Pro His Pro
Lys Pro Pro His
Lys Pro Ser Phe
Lys Pro Tyr Ala
Lys Ser Phe Pro
Lys Ser Ile Met
Lys Ser Leu Met
Lys Ser Met Ile
Lys Ser Met Leu
Lys Ser Pro Phe
Lys Thr Glu Thr
Lys Thr Met Val
Lys Thr Thr Glu
Lys Thr Val Met
Lys Val Met Thr
Lys Val Thr Met
Lys Tyr Ala Pro
Lys Tyr Pro Ala
Leu Ala Phe Gln
Leu Ala Gln Phe
Leu Cys Arg Ser
Leu Cys Ser Arg
Leu Phe Ala Gln
Leu Phe Gln Ala
Leu Lys Met Ser
Leu Lys Ser Met
Leu Met Lys Ser
Leu Met Ser Lys
Leu Gln Ala Phe
Leu Gln Phe Ala
Leu Arg Cys Ser
Leu Arg Ser Cys
Leu Ser Cys Arg
Leu Ser Lys Met
Leu Ser Met Lys
Leu Ser Arg Cys
Met Ala Arg Thr
Met Ala Thr Arg
Met Ile Lys Ser
Met Ile Ser Lys
Met Lys Ile Ser
Met Lys Leu Ser
Met Lys Ser Ile
Met Lys Ser Leu
Met Lys Thr Val
Met Lys Val Thr
Met Leu Lys Ser
Met Leu Ser Lys
Met Arg Ala Thr
Met Arg Thr Ala
Met Ser Ile Lys
Met Ser Lys Ile
Met Ser Lys Leu
Met Ser Leu Lys
Met Thr Ala Arg
Met Thr Lys Val
Met Thr Arg Ala
Met Thr Val Lys
Met Val Lys Thr
Met Val Thr Lys
Asn Phe Val Val
Asn Val Phe Val
Asn Val Val Phe
Pro Ala Lys Tyr
Pro Ala Tyr Lys
Pro Phe Lys Ser
Pro Phe Ser Lys
Pro His Lys Pro
Pro His Pro Lys
Pro His Pro Gln
Pro His Gln Pro
Pro Lys Ala Tyr
Pro Lys Phe Ser
Pro Lys His Pro
Pro Lys Pro His
Pro Lys Ser Phe
Pro Lys Tyr Ala
Pro Pro His Lys
Pro Pro His Gln
Pro Pro Lys His
Pro Pro Gln His
Pro Gln His Pro
Pro Gln Pro His
Pro Ser Phe Lys
Pro Ser Lys Phe
Pro Tyr Ala Lys
Pro Tyr Lys Ala
Gln Ala Phe Ile
Gln Ala Phe Leu
Gln Ala Ile Phe
Gln Ala Leu Phe
Gln Phe Ala Ile
Gln Phe Ala Leu
Gln Phe Ile Ala
Gln Phe Leu Ala
Gln His Pro Pro
Gln Ile Ala Phe
Gln Ile Phe Ala
Gln Leu Ala Phe
Gln Leu Phe Ala
Gln Pro His Pro
Gln Pro Pro His
Arg Ala Met Thr
Arg Ala Thr Met
Arg Cys Ile Ser
Arg Cys Leu Ser
Arg Cys Ser Ile
Arg Cys Ser Leu
Arg Cys Thr Val
Arg Cys Val Thr
Arg Phe Gly Val
Arg Phe Val Gly
Arg Gly Phe Val
Arg Gly Val Phe
Arg Ile Cys Ser
Arg Ile Ser Cys
Arg Leu Cys Ser
Arg Leu Ser Cys
Arg Met Ala Thr
Arg Met Thr Ala
Arg Ser Cys Ile
Arg Ser Cys Leu
Arg Ser Ile Cys
Arg Ser Leu Cys
Arg Thr Ala Met
Arg Thr Cys Val
Arg Thr Met Ala
Arg Thr Thr Thr
Arg Thr Val Cys
Arg Val Cys Thr
Arg Val Phe Gly
Arg Val Gly Phe
Arg Val Thr Cys
Ser Cys Ile Arg
Ser Cys Leu Arg
Ser Cys Arg Ile
Ser Cys Arg Leu
Ser Phe Lys Pro
Ser Phe Pro Lys
Ser Ile Cys Arg
Ser Ile Lys Met
Ser Ile Met Lys
Ser Ile Arg Cys
Ser Lys Phe Pro
Ser Lys Ile Met
Ser Lys Leu Met
Ser Lys Met Ile
Ser Lys Met Leu
Ser Lys Pro Phe
Ser Leu Cys Arg
Ser Leu Lys Met
Ser Leu Met Lys
Ser Leu Arg Cys
Ser Met Ile Lys
Ser Met Lys Ile
Ser Met Lys Leu
Ser Met Leu Lys
Ser Pro Phe Lys
Ser Pro Lys Phe
Ser Arg Cys Ile
Ser Arg Cys Leu
Ser Arg Ile Cys
Ser Arg Leu Cys
Thr Ala Met Arg
Thr Ala Arg Met
Thr Cys Arg Val
Thr Cys Val Arg
Thr Glu Lys Thr
Thr Glu Thr Lys
Thr Lys Glu Thr
Thr Lys Met Val
Thr Lys Thr Glu
Thr Lys Val Met
Thr Met Ala Arg
Thr Met Lys Val
Thr Met Arg Ala
Thr Met Val Lys
Thr Arg Ala Met
Thr Arg Cys Val
Thr Arg Met Ala
Thr Arg Thr Thr
Thr Arg Val Cys
Thr Thr Glu Lys
Thr Thr Lys Glu
Thr Thr Arg Thr
Thr Thr Thr Arg
Thr Val Cys Arg
Thr Val Lys Met
Thr Val Met Lys
Thr Val Arg Cys
Val Cys Arg Thr
Val Cys Thr Arg
Val Phe Gly Arg
Val Phe Asn Val
Val Phe Arg Gly
Val Phe Val Asn
Val Gly Phe Arg
Val Gly Arg Phe
Val Lys Met Thr
Val Lys Thr Met
Val Met Lys Thr
Val Met Thr Lys
Val Asn Phe Val
Val Asn Val Phe
Val Arg Cys Thr
Val Arg Phe Gly
Val Arg Gly Phe
Val Arg Thr Cys
Val Thr Cys Arg
Val Thr Lys Met
Val Thr Met Lys
Val Thr Arg Cys
Val Val Phe Asn
Val Val Asn Phe
Tyr Ala Lys Pro
Tyr Ala Pro Lys
Tyr Lys Ala Pro
Tyr Lys Pro Ala
Tyr Pro Ala Lys
Tyr Pro Lys Ala
almitrine
R - Respiratory system > R07 - Other respiratory system products > R07A - Other respiratory system products > R07AB - Respiratory stimulants COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C78272 - Agent Affecting Nervous System > C47795 - CNS Stimulant D019141 - Respiratory System Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
1'-O-Acetylpaxilline
ibha#16
A 4-O-(1H-indol-3-ylcarbonyl)ascaroside that is icas#16 in which the pro-R hydrogen beta to the carboxy group is replaced by a hydroxy group. It is a metabolite of the nematode Caenorhabditis elegans.
ibho#16
An omega-hydroxy fatty acid ascaroside that is bhos#16 in which the hydroxy group at position 4 of the ascarylopyranose moiety has been has been converted to the corresponding 1H-indole-3-carboxylate ester. It is a metabolite of the nematode Caenorhabditis elegans.
Torate
D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D009292 - Narcotic Antagonists D019141 - Respiratory System Agents > D000996 - Antitussive Agents C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent D002491 - Central Nervous System Agents > D000700 - Analgesics
9,9-dimethyl-N-(9,9-dimethyl-9H-fluoren-2-yl)-N-phenyl-9H-fluoren-2-amine
(E)-7-[2-morpholin-4-yl-3-oxo-5-[(4-phenylphenyl)methoxy]cyclopentyl]hept-4-enoic acid
D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents
(3R)-10-[[3,6-Dideoxy-4-O-(1H-indol-3-ylcarbonyl)-alpha-L-arabino-hexopyranosyl]oxy]-3-hydroxydecanoic acid
(3R,9R)-9-{[3,6-dideoxy-4-O-(1H-indol-3-ylcarbonyl)-alpha-L-arabino-hexopyranosyl]oxy}-3-hydroxydecanoic acid
(1R,2S,4R,5R,8R,9S,11S)-9-formyl-5-methyl-13-propan-2-yl-2-[[(2R,3S,4R,5S,6R)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]tetracyclo[7.4.0.02,11.04,8]tridec-12-ene-1-carboxylate
(13E)-4,8-dihydroxy-5,5,7,9-tetramethyl-16-[(E)-1-(2-methyl-1,3-thiazol-4-yl)prop-1-en-2-yl]-1-oxacyclohexadec-13-ene-2,6-dione
(1R,3aR,4S,4aR,7R,7aR,8aS)-8a-{[(6-deoxy-beta-D-altropyranosyl)oxy]methyl}-4-formyl-7-methyl-3-(propan-2-yl)-4,4a,5,6,7,7a,8,8a-octahydro-1,4-methano-s-indacene-3a(1H)-carboxylate
3-(3,5-dimethyl-4-isoxazolyl)-1-[[(8S,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-1-methylurea
3-(3,5-dimethyl-4-isoxazolyl)-1-[[(8R,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-1-methylurea
3-(3,5-dimethyl-4-isoxazolyl)-1-[[(8S,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-1-methylurea
3-(3,5-dimethyl-4-isoxazolyl)-1-[[(8S,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-1-methylurea
3-(3,5-dimethyl-4-isoxazolyl)-1-[[(8R,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-1-methylurea
3-(3,5-dimethyl-4-isoxazolyl)-1-[[(8S,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-1-methylurea
3-(3,5-dimethyl-4-isoxazolyl)-1-[[(8R,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-1-methylurea
3-(3,5-dimethyl-4-isoxazolyl)-1-[[(8R,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-1-methylurea
(4Z)-7-{5-[([1,1-biphenyl]-4-yl)methoxy]-2-(morpholin-4-yl)-3-oxocyclopentyl}hept-4-enoic acid
3-(3,5-dimethyl-4-isoxazolyl)-1-[[(8R,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-1-methylurea
3-(3,5-dimethyl-4-isoxazolyl)-1-[[(8S,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-1-methylurea
3-(3,5-dimethyl-4-isoxazolyl)-1-[[(8S,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-1-methylurea
(2R,3R,3aS,9bS)-7-(cyclopenten-1-yl)-N-(cyclopropylmethyl)-1-[(2-fluorophenyl)methyl]-3-(hydroxymethyl)-6-oxo-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
3-(3,5-dimethyl-4-isoxazolyl)-1-[[(8R,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-1-methylurea
3-(3,5-dimethyl-4-isoxazolyl)-1-[[(8S,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-1-methylurea
3-(3,5-dimethyl-4-isoxazolyl)-1-[[(8R,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-1-methylurea
(2S,3S,3aR,9bR)-7-(cyclopenten-1-yl)-N-(cyclopropylmethyl)-1-[(2-fluorophenyl)methyl]-3-(hydroxymethyl)-6-oxo-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
3-(3,5-dimethyl-4-isoxazolyl)-1-[[(8R,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-1-methylurea
N-[[(2S,3S)-8-(1-cyclohexenyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylbenzamide
N-[[(10S,11R)-13-[(2S)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-N-methylacetamide
N-[(2S,3R,6S)-2-(hydroxymethyl)-6-[2-oxo-2-(4-phenylanilino)ethyl]-3,6-dihydro-2H-pyran-3-yl]-3-(1-piperidinyl)propanamide
N-[(2R,3R,6S)-2-(hydroxymethyl)-6-[2-oxo-2-(4-phenylanilino)ethyl]-3,6-dihydro-2H-pyran-3-yl]-3-(1-piperidinyl)propanamide
N-[(2R,3R,6R)-2-(hydroxymethyl)-6-[2-oxo-2-(4-phenylanilino)ethyl]-3,6-dihydro-2H-pyran-3-yl]-3-(1-piperidinyl)propanamide
N-[[(10R,11R)-13-[(2S)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-N-methylacetamide
N-[[(10S,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-N-methylacetamide
(1S)-1-(hydroxymethyl)-7-methoxy-1-[1-oxo-2-(3-pyridinyl)ethyl]-N-propyl-2-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]carboxamide
[(1R)-1-ethylsulfonyl-7-methoxy-9-methyl-2-(4-oxanylmethyl)-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]yl]methanol
cyclopropyl-[(1S)-2-[(2-fluorophenyl)methyl]-1-(hydroxymethyl)-7-methoxy-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]yl]methanone
1-[(1S)-1-(hydroxymethyl)-7-methoxy-1-[(2-methoxyphenyl)methyl]-9-methyl-2-spiro[1,3-dihydropyrido[3,4-b]indole-4,4-piperidine]yl]ethanone
3-(3,5-dimethyl-4-isoxazolyl)-1-[[(8S,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-1-methylurea
N-[[(10R,11R)-13-[(2R)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-N-methylacetamide
N-[[(10R,11S)-13-[(2R)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-N-methylacetamide
N-[[(10S,11R)-13-[(2R)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-N-methylacetamide
N-[(2R,3S,6S)-2-(hydroxymethyl)-6-[2-oxo-2-(4-phenylanilino)ethyl]-3,6-dihydro-2H-pyran-3-yl]-3-(1-piperidinyl)propanamide
N-[(2S,3S,6R)-2-(hydroxymethyl)-6-[2-oxo-2-(4-phenylanilino)ethyl]-3,6-dihydro-2H-pyran-3-yl]-3-(1-piperidinyl)propanamide
N-[(2S,3S,6S)-2-(hydroxymethyl)-6-[2-oxo-2-(4-phenylanilino)ethyl]-3,6-dihydro-2H-pyran-3-yl]-3-(1-piperidinyl)propanamide
N-[[(10S,11S)-13-[(2R)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-N-methylacetamide
(1R)-1-(hydroxymethyl)-7-methoxy-1-[1-oxo-2-(3-pyridinyl)ethyl]-N-propyl-2-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]carboxamide
[(1S)-1-ethylsulfonyl-7-methoxy-9-methyl-2-(4-oxanylmethyl)-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]yl]methanol
1-[(1R)-1-(hydroxymethyl)-7-methoxy-1-[(2-methoxyphenyl)methyl]-9-methyl-2-spiro[1,3-dihydropyrido[3,4-b]indole-4,4-piperidine]yl]ethanone
(2R,3S)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-8-[2-(4-methoxyphenyl)ethynyl]-3-methyl-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
1-[(1S)-1-ethylsulfonyl-1-(hydroxymethyl)-7-methoxy-9-methyl-2-spiro[1,3-dihydropyrido[3,4-b]indole-4,4-piperidine]yl]-1-butanone
1-[(1R)-1-ethylsulfonyl-1-(hydroxymethyl)-7-methoxy-9-methyl-2-spiro[1,3-dihydropyrido[3,4-b]indole-4,4-piperidine]yl]-1-butanone
1,3-benzodioxol-5-yl-[(1S)-1-(hydroxymethyl)-7-methoxy-2,9-dimethyl-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,4-piperidine]yl]methanone
1,3-benzodioxol-5-yl-[(1R)-1-(hydroxymethyl)-7-methoxy-2,9-dimethyl-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,4-piperidine]yl]methanone
[(1S)-2-(1,3-benzodioxol-5-ylmethyl)-7-methoxy-1-propyl-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]yl]methanol
6,7,7,10,10,13-Hexamethylspiro[1,8-dihydropyrano[2,3-g]indole-3,11-3,13-diazatetracyclo[5.5.2.01,9.03,7]tetradecane]-2,9,14-trione
(Z)-7-[(1R,2R,5S)-2-morpholin-4-yl-3-oxo-5-[(4-phenylphenyl)methoxy]cyclopentyl]hept-4-enoic acid
D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents
(4Z)-7-[(1S,2S,5R)-5-[([1,1-Biphenyl]-4-yl)methoxy]-2-(morpholin-4-yl)-3-oxocyclopentyl]hept-4-enoic acid
D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents
4-O-demethylsordarin(1-)
A 3-oxo monocarboxylic acid anion that is the conjugate base of 4-O-demethylsordarin, arising from deprotonation of the carboxy group; major species at pH 7.3.
butorphanol D-tartrate
The (S,S)-tartaric acid salt of butorphanol. It is used for relief or moderate to severe pain.
PC(14:2)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
14,26-dihydroxy-2-methoxy-9,9,16,16-tetramethyl-8-oxa-14,23,25-triazaheptacyclo[17.5.2.0¹,¹⁷.0³,¹⁵.0⁴,¹³.0⁷,¹².0¹⁹,²³]hexacosa-3(15),4,6,10,12,25-hexaen-24-one
(1'r,3r,3's,7'r,12'r)-2,12'-dihydroxy-4',4',7,7,12',14'-hexamethyl-9',14'-diazaspiro[chromeno[5,6-b]pyrrole-3,5'-tetracyclo[5.5.2.0¹,⁹.0³,⁷]tetradecan]-13'-one
9,13'-dihydroxy-4,4,4',4',11'-pentamethyl-9',14'-diazaspiro[[1,4]dioxepino[2,3-g]indole-8,5'-tetracyclo[5.5.2.0¹,⁹.0³,⁷]tetradecan]-13'-en-10'-one
(1r,2s,17s,19s)-14,26-dihydroxy-2-methoxy-9,9,16,16-tetramethyl-8-oxa-14,23,25-triazaheptacyclo[17.5.2.0¹,¹⁷.0³,¹⁵.0⁴,¹³.0⁷,¹².0¹⁹,²³]hexacosa-3(15),4,6,10,12,25-hexaen-24-one
(4s,7r,8s,9s,16s)-4,8-dihydroxy-5,5,7,9-tetramethyl-16-[(1e)-1-(2-methyl-1,3-thiazol-4-yl)prop-1-en-2-yl]-1-oxacyclohexadec-13-ene-2,6-dione
(1s,12r,15r)-1-hydroxy-7-methoxy-10-(3-methylbut-2-en-1-yl)-12-(2-methylprop-1-en-1-yl)-10,13,19-triazapentacyclo[11.7.0.0³,¹¹.0⁴,⁹.0¹⁵,¹⁹]icosa-3(11),4,6,8-tetraene-2,14,20-trione
16-benzyl-13,18-dihydroxy-9,15-dimethyl-14-methylidene-6h,7h,8h,9h,10h,12ah,13h,15h,15ah,16h-oxacyclotetradeca[2,3-d]isoindole-2,5-dione
(1's,3r,3's,12'r)-2,12'-dihydroxy-4',4',7,7,12',14'-hexamethyl-9',14'-diazaspiro[chromeno[5,6-b]pyrrole-3,5'-tetracyclo[5.5.2.0¹,⁹.0³,⁷]tetradecan]-13'-one
(1's,8r,8's,10's)-9-hydroxy-4,4,11',11',14'-pentamethyl-3',14'-diazaspiro[[1,4]dioxepino[2,3-g]indole-8,12'-tetracyclo[6.5.2.0¹,¹⁰.0³,⁸]pentadecan]-15'-one
20-deoxyspiganthine
{"Ingredient_id": "HBIN003395","Ingredient_name": "20-deoxyspiganthine","Alias": "NA","Ingredient_formula": "C25H35NO8","Ingredient_Smile": "CC1CCC2(C3(CC4(C5(C(C3C(C5(C(C)C)O)OC(=O)C6=CC=CN6)(C2(C1O)O4)O)C)O)C)O","Ingredient_weight": "477.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "5214","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "100991756","DrugBank_id": "NA"}